Pacific Edge Ramps up Clinical Utility Studies, Commercial Efforts Behind Bladder Cancer Test
The New Zealand-based diagnostics firm is hoping the coming year will be a tipping point toward new guideline inclusion and broader adoption.
New Lung Cancer Evolution, Treatment Response Patterns Emerge From TRACERx Study
TRACERx researchers reported on non-small cell lung cancer features linked to disease progression, recurrence, treatment response, and more in seven new papers.
Predictive Oncology, Cvergenx Partner for Personalized Radiation Therapy, Drug Discovery
The firms aim to combine their platforms to develop genomics- and machine learning-informed approaches to personalized radiation therapy.
The company has derived and validated a mutational and gene expression score that predicts immunotherapy benefit across tumor types.
Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response
With drug sensitivity and genomic profiles on acute lymphoblastic leukemia cells, coupled with patient data, researchers saw pharmacotypes related to treatment response and outcomes.